MiMedx to Participate at the H.C. Wainwright BioConnect 2021 Conference

Rhea-AI Summary

MARIETTA, Ga., Jan. 4, 2021 – MiMedx Group (Nasdaq: MDXG) announced that CEO Timothy R. Wright and EVP Dr. Robert Stein will participate in a fireside chat at the H.C. Wainwright BioConnect 2021 Virtual Conference from January 11-14, 2021. The chat will be pre-recorded and available on MiMedx's Investors webpage starting January 11 at 6:00 AM ET, accessible for 90 days. MiMedx is a leader in advanced wound care and therapeutic biologics, specializing in human placental tissue allografts using its proprietary PURION® process.

MARIETTA, Ga., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Dr. Robert Stein, Executive Vice President, Research & Development, will participate in a fireside chat at the H.C. Wainwright BioConnect 2021 Virtual Conference held January 11-14, 2021.

The pre-recorded fireside chat will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com beginning on Monday, January 11, 2021 at 6:00 AM Eastern Time and will be accessible for approximately 90 days.

About MiMedx
MiMedx^® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION^® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contacts:
Investors
Jack Howarth
404-360-5681
investorrelations@mimedx.com

FAQ

When will MiMedx participate in the BioConnect 2021 Conference?

MiMedx will participate in the H.C. Wainwright BioConnect 2021 Virtual Conference from January 11-14, 2021.

Where can I watch the MiMedx fireside chat?

The fireside chat will be available on the Investors section of MiMedx's website starting January 11, 2021, at 6:00 AM ET.

What is the focus of MiMedx's fireside chat at the conference?

The focus will be on advanced wound care and therapeutic biologics, highlighting MiMedx's innovations.

How long will the pre-recorded chat be accessible?

The chat will be accessible for approximately 90 days after its release.

What does MiMedx specialize in?

MiMedx specializes in human placental tissue allografts for advanced wound care using its PURION® process.